Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.

Khorana AA, Streiff MB, Farge D, Mandala M, Debourdeau P, Cajfinger F, Marty M, Falanga A, Lyman GH.

J Clin Oncol. 2009 Oct 10;27(29):4919-26. doi: 10.1200/JCO.2009.22.3214. Epub 2009 Aug 31. Review.

2.

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW; American Society of Clinical Oncology.

J Clin Oncol. 2007 Dec 1;25(34):5490-505. Epub 2007 Oct 29. Review.

PMID:
17968019
3.

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR.

J Thromb Haemost. 2013 Jan;11(1):56-70. doi: 10.1111/jth.12070. Review.

4.

Prophylaxis and treatment of venous thromboembolism in cancer patients: a review.

Ansell JE.

Am J Clin Oncol. 2009 Aug;32(4 Suppl):S8-S12. doi: 10.1097/COC.0b013e3181b01c06. Review.

PMID:
19654482
5.

Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.

Al-Hameed F, Al-Dorzi HM, AlMomen A, Algahtani F, AlZahrani H, AlSaleh K, AlSheef M, Owaidah T, Alhazzani W, Neumann I, Wiercioch W, Brozek J, Schünemann H, Akl EA.

Ann Saudi Med. 2015 Mar-Apr;35(2):95-106. doi: 10.5144/0256-4947.2015.95.

6.

Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

Kuderer NM, Ortel TL, Francis CW.

J Clin Oncol. 2009 Oct 10;27(29):4902-11. doi: 10.1200/JCO.2009.22.4584. Epub 2009 Sep 8. Review.

7.

Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.

Farge D, Durant C, Villiers S, Long A, Mahr A, Marty M, Debourdeau P; Groupe Francophone Thrombose et Cancer (GFTC).

Thromb Res. 2010 Apr;125 Suppl 2:S108-16. doi: 10.1016/S0049-3848(10)70027-X. Review.

PMID:
20433988
8.

Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.

Lyman GH.

Cancer. 2011 Apr 1;117(7):1334-49. doi: 10.1002/cncr.25714. Epub 2010 Nov 8. Review.

9.

Venous thromboembolism in cancer patients.

Deng A, Galanis T, Graham MG.

Hosp Pract (1995). 2014 Dec;42(5):24-33. doi: 10.3810/hp.2014.12.1156. Review.

PMID:
25485915
10.

Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer.

Lyman GH.

Cancer. 2009 Dec 15;115(24):5637-50. doi: 10.1002/cncr.24665. Review.

11.

Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.

Brown A.

Am J Health Syst Pharm. 2012 Mar 15;69(6):469-81. doi: 10.2146/ajhp110187. Review.

PMID:
22382477
12.

Prevention of venous thromboembolism in hospitalized patients with cancer.

Francis CW.

J Clin Oncol. 2009 Oct 10;27(29):4874-80. doi: 10.1200/JCO.2009.22.3644. Epub 2009 Aug 24. Review.

13.

Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.

Petersen LJ.

Cancer Treat Rev. 2009 Dec;35(8):754-64. doi: 10.1016/j.ctrv.2009.08.009. Epub 2009 Sep 16. Review.

PMID:
19762155
15.

How to improve the implementation of guidelines on cancer-related thrombosis.

Debourdeau P, Beckers M, Gérôme P, Durant C, Lacoin Q, Debourdeau A, Bancel DF.

Expert Rev Anticancer Ther. 2011 Mar;11(3):473-83. doi: 10.1586/era.11.1. Review.

PMID:
21417859
16.

Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.

van Es N, Bleker SM, Wilts IT, Porreca E, Di Nisio M.

Drugs. 2016 Mar;76(3):331-41. doi: 10.1007/s40265-015-0526-3. Review.

PMID:
26729187
17.

Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.

Schoot RA, Kremer LC, van de Wetering MD, van Ommen CH.

Cochrane Database Syst Rev. 2013 Sep 11;(9):CD009160. doi: 10.1002/14651858.CD009160.pub2. Review.

PMID:
24026801
18.

Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.

Ay C, Pabinger I.

Hamostaseologie. 2012;32(2):139-44. doi: 10.5482/ha-1168. Epub 2011 Aug 8. Review.

PMID:
21822525
19.

Management of venous thromboembolism and the potential to impact overall survival in patients with cancer.

Saraiya B, Goodin S.

Pharmacotherapy. 2009 Nov;29(11):1344-56. doi: 10.1592/phco.29.11.1344. Review.

PMID:
19857150
20.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445

Supplemental Content

Support Center